Clinical trial

Nesfatin-1 Level in Patients With Type 2 Diabetes, Insulin Resistance and Obesity

NCT04298515

Study summary

ClinicalTrials.gov

Nesfatin-1 Level in Patients With Type 2 Diabetes, Insulin Resistance and Obesity

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIAGNOSTIC_TEST · Unmapped registry intervention Nesfatin-1 Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2020-03-02

PhaseNA

Conditions

Type 2 Diabetesverified · MONDO: type 2 diabetes mellitus

Insulin Resistanceunresolved

Obesityverified · MONDO: obesity disorder

Nesfatin-1unresolved

Interventions

Nesfatin-1DIAGNOSTIC_TEST

Sponsors & collaborators

Istanbul Medeniyet Universitylead sponsor

Mapped research locations

IstanbulTurkey (Türkiye)1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04298515 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.